Sign in

CIK 0001395937 · Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320162505
Phone
781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. 10-K Report Annual Report
  3. 8-K Event Results of operations
  4. SC 13G Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. 4 Grant or award Chief Executive Officer acquired 146,250 shares (grant or award)
  9. 4 Other acquisition Chief Financial Officer acquired 2,045 shares (other)
  10. 4 Grant or award President, Head of R&D acquired 47,813 shares (grant or award)
  11. 4 Grant or award Director acquired 17,000 shares (grant or award)
  12. 4 Grant or award Director acquired 17,000 shares (grant or award)
  13. 4 Grant or award Director acquired 17,000 shares (grant or award)
  14. 4 Grant or award Director acquired 17,000 shares (grant or award)
  15. 4 Grant or award Director acquired 17,000 shares (grant or award)
  16. 4 Grant or award Director acquired 34,000 shares (grant or award)
  17. 4 Grant or award Director acquired 17,000 shares (grant or award)
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. SC 13G/A Stake Amended Statement of Ownership

Page 8 of 33 · 660 filings